Phase I and II trials of novel anti-cancer agents: endpoints, efficacy and existentialism. The Michel Clavel Lecture, held at the 10th NCI-EORTC Conference on New Drugs in Cancer Therapy, Amsterdam, 16-19 June 1998.
作者信息
Eisenhauer E A
机构信息
Investigational New Drug Program, NCIC Clinical Trials Group, Queen's University, Kingston, Ontario, Canada.
出版信息
Ann Oncol. 1998 Oct;9(10):1047-52. doi: 10.1023/a:1008497110734.
PMID:9834816
Abstract
摘要
Zotero 插件